Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSylvania Platinum Regulatory News (SLP)

Share Price Information for Sylvania Platinum (SLP)

Share Price is delayed by 15 minutes
Get Live Data
91.50    -1.10 (-1.18%)
Bid:
91.00
Ask:
92.00
Spread: 1.00 (1.099%)
Market Cap: £237.86m
SLP Live PriceLast checked at - London Stock Exchange

Intraday Sylvania Platinum Share Chart

Comment on press speculation

11 Jun 2015 07:01

RNS Number : 8391P
Sylvania Platinum Limited
11 June 2015
 

 

 

 

 

 

 

_____________________________________________________________________________________________________________________________

 

Sylvania Platinum Limited

("Sylvania" or "the Company")

 AIM (SLP)

 

 

11 June 2015

 

Comment on press speculation

On 9 June 2015 two South African newspapers, the Beeld and the Vryburger, published articles claiming that the Environmental Impact Assessment ("EIA") for the Volspruit development submitted by Sylvania was rejected by the Limpopo Department of Economic Development, Environment and Tourism ("LEDET"), requiring that the application process be restarted.

Sylvania hereby confirms that the interpretation by the newspaper journalists is incorrect.

On 20 May 2015, LEDET formally requested clarification on matters related to water consumption by the project and requested that additional work on the EIA be done to include a Biodiversity and Wetland Offset Strategy to address any potential loss of flora and fauna species or potential damage to the wetland located near the northern mining pit perimeter. Such an Offset Strategy is accepted mitigation against the risk of potential loss of classified sensitive biodiversity in terms of Environmental legislation and is generally only done at the specific request of LEDET.

During the past week the Environmental Assessment Practitioner ("EAP") released a statement to Interested and Affected Parties ("I&APs") detailing the latest correspondence received from LEDET, and explained that meetings would be held with LEDET to confirm further actions to be taken by the Company to address their concerns and submit an amendment to the EIA.

Sylvania has until 19 July 2015 to submit the amended EIA as detailed above and this should be the final stage of the process.

Sylvania respects the request for clarification and additional mitigation by LEDET as this will allow the Authority to reach a defendable decision. Sylvania will be ready to submit the required clarification and a suitable Offset Strategy for consideration by LEDET prior to the due date.

Sylvania remains optimistic that the Application will be granted as the detailed Environmental Impact Study - the culmination of some four years' effort by a considerable team of specialists - did not find any fatal flaws within the proposed project.

 

Registered office: Sylvania Platinum Limited

Clarendon House

2 Church Street

Hamilton HM 11

Bermuda

Postal address: PO Box 976

Florida Hills, 1716

South Africa

Sylvania Website: www.sylvaniaplatinum.com

 

CONTACT DETAILS

 

For further information, please contact:

Terence McConnachie (Chief Executive Officer)

+44 777 533 7175

 

Nominated Advisor and Joint Broker:

Liberum Capital Limited

Richard Crawley/Tom Fyson

+44 (0) 20 3100 2000

 

Joint Broker

GMP Securities Europe LLP

Richard Greenfield/ Alexandra Carse

+44 (0) 20 7647 2800

 

Communications:

Newgate

Tim Thompson / Adam Lloyd / Ed Treadwell / Helena Bogle

+44 (0) 20 7653 9850

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
SPCBBLLFEQFZBBE
Date   Source Headline
27th Jul 20234:11 pmRNSFourth Quarter Report to 30 June 2023
27th Jul 20237:00 amRNSFourth Quarter Report to 30 June 2023
14th Jul 202312:35 pmRNSCancellation of Ordinary Shares
3rd Jul 20237:00 amRNSShare Buyback Update
30th Jun 20237:00 amRNSShare Buyback Update
29th Jun 20237:00 amRNSShare Buyback Update
28th Jun 20237:00 amRNSShare Buyback Update
27th Jun 20237:00 amRNSShare Buyback Update
26th Jun 20237:00 amRNSShare Buyback Update
23rd Jun 20237:00 amRNSShare Buyback Update
22nd Jun 20237:00 amRNSShare Buyback Update
21st Jun 20237:00 amRNSShare Buyback Update
20th Jun 20237:00 amRNSShare Buyback Update
15th Jun 202312:22 pmRNSShare Buyback Update
14th Jun 20237:00 amRNSShare Buyback Update
13th Jun 20237:00 amRNSShare Buyback Update
8th Jun 20237:00 amRNSShare Buyback Update
7th Jun 20237:00 amRNSShare Buyback Update
12th May 20237:00 amRNSShare Buyback
2nd May 20237:00 amRNSShare Buyback
28th Apr 20237:00 amRNS3rd Quarter Results
31st Mar 20231:55 pmRNSNotice of Transaction by PDMR
21st Feb 20237:00 amRNSUpdated Corporate Investor Presentation
21st Feb 20237:00 amRNSHalf-year Report
30th Jan 20237:00 amRNSSecond Quarter Report to 31 December 2022
16th Dec 20227:00 amRNSCancellation of Ordinary Shares
28th Nov 20227:00 amRNSResult of Annual General Meeting
31st Oct 20227:00 amRNS1st Quarter Results
28th Oct 20227:00 amRNSNotice of AGM
24th Oct 20227:00 amRNSResults of Initial Optimisation Studies
30th Sep 20227:00 amRNSExercise of Vested Shares and Buyback
8th Sep 20227:00 amRNSPublication of Corporate Investor Presentation
8th Sep 20227:00 amRNSAnnual Results Announcement
28th Jul 20227:00 amRNSFourth Quarter Report to 30 June 2022
11th Jul 20227:00 amRNSNotice of Results and Update
1st Jul 20227:00 amRNSNotice of Transaction by PDMR
1st Jul 20227:00 amRNSShare Buyback Update
30th Jun 20227:00 amRNSShare Buyback Update
29th Jun 20227:00 amRNSShare Buyback Update
28th Jun 20227:00 amRNSShare Buyback Update
27th Jun 20227:00 amRNSCancellation of Ordinary Shares
24th Jun 20227:05 amRNSShare Buyback Update
23rd Jun 20227:00 amRNSShare Buyback Update
22nd Jun 20227:00 amRNSShare Buyback Update
21st Jun 20227:00 amRNSShare Buyback Update
20th Jun 20227:00 amRNSShare Buyback Update
17th Jun 20227:00 amRNSShare Buyback Update
16th Jun 202210:44 amRNSShare Buyback Update
15th Jun 20227:00 amRNSShare Buyback Update
14th Jun 20227:00 amRNSShare Buyback Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.